Heron Therapeutics (NASDAQ:HRTX) Downgraded to Hold Rating by StockNews.com
StockNews.com downgraded shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday. Separately, Needham & Company LLC restated a “buy” rating and issued a $4.00 target price on shares of Heron Therapeutics in a report on Wednesday, December 4th. Check […]
More Stories
Humanscape (HUM) 24-Hour Volume Tops $3.12 Million
Humanscape (HUM) traded 2.6% lower against the US dollar during the 24 hour period ending at 12:00 PM ET on...
Seele-N (SEELE) Price Reaches $0.0004 on Exchanges
Seele-N (SEELE) traded 0.1% higher against the US dollar during the twenty-four hour period ending at 12:00 PM Eastern on...
Persistence (XPRT) Price Down 8% Over Last Week
Persistence (XPRT) traded 5.8% higher against the US dollar during the 1-day period ending at 12:00 PM ET on December...
LCX Trading 24.1% Lower This Week (LCX)
LCX (LCX) traded down 7.7% against the U.S. dollar during the one day period ending at 12:00 PM ET on...
Stock Traders Buy High Volume of QuantumScape Call Options (NYSE:QS)
QuantumScape Co. (NYSE:QS – Get Free Report) was the target of some unusual options trading activity on Friday. Stock investors...
iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ) Sees Large Volume Increase – Should You Buy?
iShares iBonds Dec 2025 Term Corporate ETF (NYSEARCA:IBDQ – Get Free Report) saw an uptick in trading volume on Friday...